MedPath

Investigation on involvement of oxidative stress and glycosylation stress in patients with cardiovascular disease

Phase 3
Conditions
Cardiovascular diseases
Registration Number
JPRN-jRCTs032180156
Lead Sponsor
Yokoyama Miho
Brief Summary

Measurement of skin and subcutaneous AGEs was easy and safe. Forearm-measured AGEs values were significantly higher in the event group. In addition, analysis of the secondary endpoints of endothelial function and change in HbA1c was difficult due to differences in the study protocol and the patient's informed consent form.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
97
Inclusion Criteria

1.Coronary artery disease
2.Valvular disease
3.Heart failure
4.Arrhythmia
5.Aortic disease
6.Peripheral arterial disease
7.Cerebrovascular disease
8.Men and women over 20 years old
9.One who gained document consent by free will of the research subject after having sufficient explanation for participation in this research, with sufficient understanding.

Exclusion Criteria

1.Patients with severe complications (problems with extremity cutting, severe skin complications)
2.Other who judged that the research director is inappropriate as the research subject

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath